Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Does Alzheimer's disease begin in the brainstem?
Goran Šimić, Gabrijela Stanić, Mihovil Mladinov, et al.
Neuropathology and Applied Neurobiology (2009) Vol. 35, Iss. 6, pp. 532-554
Open Access | Times Cited: 202

Showing 1-25 of 202 citing articles:

Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Heiko Braak, Dietmar Rudolf Thal, Estifanos Ghebremedhin, et al.
Journal of Neuropathology & Experimental Neurology (2011) Vol. 70, Iss. 11, pp. 960-969
Open Access | Times Cited: 1900
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Peter T. Nelson, Irina Alafuzoff, Eileen H. Bigio, et al.
Journal of Neuropathology & Experimental Neurology (2012) Vol. 71, Iss. 5, pp. 362-381
Open Access | Times Cited: 1800
Primary age-related tauopathy (PART): a common pathology associated with human aging
John F. Crary, John Q. Trojanowski, Julie A. Schneider, et al.
Acta Neuropathologica (2014) Vol. 128, Iss. 6, pp. 755-766
Open Access | Times Cited: 1261
The neuropathology of probable Alzheimer disease and mild cognitive impairment
Julie A. Schneider, Zoe Arvanitakis, Sue E. Leurgans, et al.
Annals of Neurology (2009) Vol. 66, Iss. 2, pp. 200-208
Open Access | Times Cited: 865
The pathological process underlying Alzheimer’s disease in individuals under thirty
Heiko Braak, Kelly Del Tredici
Acta Neuropathologica (2010) Vol. 121, Iss. 2, pp. 171-181
Closed Access | Times Cited: 735
Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies
Goran Šimić, Mirjana Babić Leko, Selina Wray, et al.
Biomolecules (2016) Vol. 6, Iss. 1, pp. 6-6
Open Access | Times Cited: 610
Tau and tauopathies
Thomas Arendt, Jens Stieler, Max Holzer
Brain Research Bulletin (2016) Vol. 126, pp. 238-292
Closed Access | Times Cited: 516
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
Stephanie J. B. Vos, Chengjie Xiong, Pieter Jelle Visser, et al.
The Lancet Neurology (2013) Vol. 12, Iss. 10, pp. 957-965
Open Access | Times Cited: 512
Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons
Ravi Rajmohan, P. Hemachandra Reddy
Journal of Alzheimer s Disease (2016) Vol. 57, Iss. 4, pp. 975-999
Open Access | Times Cited: 474
The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease
Heiko Braak, Kelly Del Tredici
Brain (2015) Vol. 138, Iss. 10, pp. 2814-2833
Open Access | Times Cited: 461
Locus coeruleus volume and cell population changes during Alzheimer's disease progression: A stereological study in human postmortem brains with potential implication for early‐stage biomarker discovery
Panos Theofilas, Alexander J. Ehrenberg, Sara Dunlop, et al.
Alzheimer s & Dementia (2016) Vol. 13, Iss. 3, pp. 236-246
Open Access | Times Cited: 347
Alzheimer’s pathogenesis: is there neuron-to-neuron propagation?
Heiko Braak, Kelly Del Tredici
Acta Neuropathologica (2011) Vol. 121, Iss. 5, pp. 589-595
Closed Access | Times Cited: 331
Digital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity
Lampros Kourtis, Oliver B. Regele, Justin M. Wright, et al.
npj Digital Medicine (2019) Vol. 2, Iss. 1
Open Access | Times Cited: 323
Monoaminergic neuropathology in Alzheimer’s disease
Goran Šimić, Mirjana Babić Leko, Selina Wray, et al.
Progress in Neurobiology (2016) Vol. 151, pp. 101-138
Open Access | Times Cited: 260
“Is dopamine involved in Alzheimer's disease?”
Alessandro Martorana, Giacomo Koch
Frontiers in Aging Neuroscience (2014) Vol. 6
Open Access | Times Cited: 239
Changes in brain oxysterols at different stages of Alzheimer's disease: Their involvement in neuroinflammation
Gabriella Testa, Erica Staurenghi, Chiara Zerbinati, et al.
Redox Biology (2016) Vol. 10, pp. 24-33
Open Access | Times Cited: 236
A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia
Gill Livingston, Lynsey Kelly, Elanor Lewis-Holmes, et al.
Health Technology Assessment (2014) Vol. 18, Iss. 39
Open Access | Times Cited: 224
Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
Ester Aso, Isidró Ferrer
Frontiers in Pharmacology (2014) Vol. 5
Open Access | Times Cited: 202
Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: the pathological building blocks of early Alzheimer's disease
Alexander J. Ehrenberg, Austin Nguy, Panos Theofilas, et al.
Neuropathology and Applied Neurobiology (2017) Vol. 43, Iss. 5, pp. 393-408
Open Access | Times Cited: 188
Accurate Detection of Alzheimer’s Disease Using Lightweight Deep Learning Model on MRI Data
Ahmed A. Abd El‐Latif, Samia Allaoua Chelloug, Maali Alabdulhafith, et al.
Diagnostics (2023) Vol. 13, Iss. 7, pp. 1216-1216
Open Access | Times Cited: 47
Identification of the subventricular tegmental nucleus as brainstem reward center
Krisztián Zichó, Boldizsár Zsolt Balog, Réka Z. Sebestény, et al.
Science (2025) Vol. 387, Iss. 6732
Closed Access | Times Cited: 2
Cell number changes in Alzheimer's disease relate to dementia, not to plaques and tangles
Carlos Humberto Andrade-Moraes, Ana V. Oliveira-Pinto, Emily Castro-Fonseca, et al.
Brain (2013) Vol. 136, Iss. 12, pp. 3738-3752
Open Access | Times Cited: 190
Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia
Isidró Ferrer
Progress in Neurobiology (2012) Vol. 97, Iss. 1, pp. 38-51
Closed Access | Times Cited: 168
Lipidomics of Human Brain Aging and Alzheimer's Disease Pathology
Alba Naudí, Rosanna Cabré, Mariona Jové, et al.
International review of neurobiology (2015), pp. 133-189
Closed Access | Times Cited: 162
Precortical Phase of Alzheimer's Disease (AD)‐Related Tau Cytoskeletal Pathology
Katharina Stratmann, Helmut Heinsen, Horst‐Werner Korf, et al.
Brain Pathology (2015) Vol. 26, Iss. 3, pp. 371-386
Open Access | Times Cited: 132
Page 1 - Next Page

Scroll to top